Cagent Vascular: Latest News, Top Stories & Analysis

Serranator PTA Serration Balloon Catheter

WAYNE, PA — Cagent Vascular, a developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its PRELUDE-BTK Study at this year’s LINC Symposium on January …

Cagent Vascular Announces FDA 510(k) Clearance for Its Serranator Device

April 28, 2020April 28, 2020 - by MyChesCo

WAYNE, PA — Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announced FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating …

Products and Services / Research

Cagent Vascular Initiates Enrollment of PRELUDE-BTK Study Using Serranator Device

January 13, 2020January 13, 2020 - by MyChesCo

WAYNE, PA — Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces the initiation of the PRELUDE-BTK Study.